Semaglutide is effective in achieving weight loss in liver transplant recipients

Kenneth W Chow¹, Brittney Ibrahim^{2

3}, Kabir Rahal², Ryan H Hsu⁴, Teresa Tan², Katherine Meneses², Sammy Saab^{2

3}

Affiliations

¹ Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
² Department of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
³ Department of Surgery, University of California at Los Angeles, Los Angeles, California, USA.
⁴ Department of Bioengineering, Jacobs School of Engineering, University of California, San Diego, La Jolla, California, USA.

Kenneth W Chow et al. Liver Transpl. 2024.

. 2024 Feb 1;30(2):223-225.

doi: 10.1097/LVT.0000000000000247. Epub 2023 Aug 29.

Kenneth W Chow¹, Brittney Ibrahim^{2

3}, Kabir Rahal², Ryan H Hsu⁴, Teresa Tan², Katherine Meneses², Sammy Saab^{2

3}

¹ Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
² Department of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
³ Department of Surgery, University of California at Los Angeles, Los Angeles, California, USA.
⁴ Department of Bioengineering, Jacobs School of Engineering, University of California, San Diego, La Jolla, California, USA.

No abstract available

References

1. van Son J, Stam SP, Gomes-Neto AW, Osté MCJ, Blokzijl H, van den Berg AP, et al. Post-transplant obesity impacts long-term survival after liver transplantation. Metabolism. 2020;106:154204.
1. Anastácio LR, Lima AS, Toulson Davisson Correia MI. Metabolic syndrome and its components after liver transplantation: Incidence, prevalence, risk factors, and implications. Clin Nutr. 2010;29:175–9.
1. Singh G, Krauthamer M, Bjalme-Evans M. Wegovy (semaglutide): A new weight loss drug for chronic weight management. J Investig Med. 2022;70:5–13.
1. Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989–1002.
1. Ghusn W, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feris F, et al. Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Netw Open. 2022;5:e2231982.